Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
Quick Stats
Jan 30, 202661.7
AI Score
BUY1.16
Volume Ratio
Feb 19, 2026
Next Earnings
16
+ve Days (30d)
14
-ve Days (30d)
GH Stock Summary
Last updated Jan 30, 2026
GH is currently trading at $114.04, positioned above its 200-day moving average of $68.88, indicating a long-term uptrend. The stock has a 52-week range of $34.88 to $120.74.
Technical Analysis: The 50-day moving average stands at $106.2, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 59.697, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.206, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates GH at 61.7/100 with a BUY recommendation.
GH (Guardant Health, Inc. Common Stock) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 59.697 |
| CMF (20) | 0.206 |
| ROC (10) | 1.84 |
| ADX (14) | 22.563 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 2.754 |
| AROONOSC (14) | 50.0 |
| WILLAMS %R (14) | -39.551 |
| MFI (14) | 57.558 |
GH Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
GH Price vs Max Options Open Interest
GH Max Change In Options Open Interest
GH Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
GH Daily Out of Money Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
GH Daily In the Money Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
GH Most Active Options by Volume(near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Guardant Health, Inc. Common Stock is above both 50 Day and 200 Day SMA which is considered Bullish.
GH Moving Averages Analysis
Guardant Health, Inc. Common Stock has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jan 30, 2026
Guardant Health, Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jan 30, 2026
GH (Guardant Health, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 113.77 |
| 20 | 110.88 |
| 30 | 107.52 |
| 50 | 106.2 |
| 100 | 88.84 |
| 200 | 68.88 |
GH Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 14.8 billion |
| Earnings/Share ($) | -3.32 |
| Net Proft Margin (%) | -0.4418 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -1.8057 |
| EPS Estimate Next Year ($) | -1.4396 |
| WallStreet Target Price ($) | 125.2381 |
| Most Recent Quarter |